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The Pseudomonas putida KT2440 strain was engineered in order to produce
anthranilate (oAB, ortho-aminobenzoate), a precursor of the aromatic amino acid
tryptophan, from glucose as sole carbon source. To enable the production of
the metabolic intermediate oAB, the trpDC operon encoding an anthranilate
phosphoribosyltransferase (TrpD) and an indole-3-glycerol phosphate synthase (TrpC),
were deleted. In addition, the chorismate mutase (pheA) responsible for the conversion
of chorismate over prephenate to phenylpyruvate was deleted in the background
of the deletion of trpDC to circumvent a potential drain of precursor. To further
increase the oAB production, a feedback insensitive version of 3-deoxy-D-arabino-
heptulosonate-7-phosphate synthase encoded by the aroGD146N gene and an
anthranilate synthase (trpES40FG) were overexpressed separately and simultaneously
in the deletion mutants. With optimized production conditions in a tryptophan-limited
fed-batch process a maximum of 1.54 ± 0.3 g L−1 (11.23 mM) oAB was obtained
with the best performing engineered P. putida KT2440 strain (P. putida trpDC
pSEVA234_aroGD146N_trpES40FG).
Keywords: Pseudomonas putida KT2440, anthranilic acid, aromatic amino acid pathway, metabolic engineering,
industrial biotechnology
INTRODUCTION
Anthranilate (oAB, ortho-aminobenzoate) is an aromatic acid used as a platform chemical for
the production of food ingredients (Raﬀensperger and Vogt, 1961), dyes, perfumes (Wiklund and
Bergman, 2006), crop protection compounds (Askham, 1992; Yadav andKrishnan, 1998; Chambers
et al., 2013), pharmaceutical compounds (Bahia et al., 2011; Shaﬁq et al., 2011; Haynes et al., 2012;
Gao et al., 2013; Loque and Weniger, 2013; Walsh et al., 2013), and plastics such as nylon (Sun
et al., 2013). It is currently produced in energy intensive chemical processes from petroleum-
based precursors, like phthalamic acid (Klipper and Gripper, 1981; Berg, 2009). Furthermore,
the production of the precursors and the production of oAB accumulate toxic byproducts, such
as hypochlorite which is used with molar equivalency to oAB (Berg, 2009). Thus, there is a
strong motivation to ﬁnd alternative routes to produce platform chemicals, such as oAB, in green
production processes from renewable resources in an environmental friendly way. In addition, the
development and application of green production processes is accelerated by an environmental
and political interest to be less dependent on fossil resources.
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Biocatalysis using living microbes as catalysts is a well-
established alternative for the production of chemicals. The
aromatic biosynthesis pathway and the derived compounds of
the aromatic acids, such as oAB, have been intensively studied
in the last decades (Bongaerts et al., 2001; Ikeda, 2003; Kramer
et al., 2003; Leuchtenberger et al., 2005; Pittard and Yang,
2008). Microbial production of oAB with engineered Escherichia
coli strains was reported by Balderas-Hernandez et al. (2009)
followed by further publications on oAB-derived compounds
such as catechol and muconic acid (Sun et al., 2013; Averesch
and Krömer, 2014; Balderas-Hernandez et al., 2014; Jaeger
et al., 2015). To enable oAB production in E. coli, Balderas-
Hernandez et al. (2009, 2014) inserted a point mutation in
the oAB phosphoribosyl transferase domain (trpD), whereas
Sun et al. (2013) used the Keio collection deletion strain
E. coli BW25113 trp::kan to prevent the conversion of oAB
to tryptophan. Additional targets to increase the production
of oAB in E. coli, for example the overexpression of feedback
insensitive variants of the 3-deoxy-D-arabino-heptulosonate-7-
phosphate (DAHP) synthase and the anthranilate synthase unit
(trpES40FG) were investigated. A maximum titer of 14 g L−1 oAB
was reported growing the engineered strains in complex medium
containing 30 g L−1 yeast extract (Balderas-Hernandez et al.,
2009).
Here, we present the ﬁrst attempt of microbial production
of oAB from glucose as sole carbon source with an engineered
P seudomonas putida KT2440 strain. Due to its versatile
metabolism and low nutritional requirements P. putida is
an eﬃcient production strain for various industrial relevant
products (Tiso et al., 2014). In addition its high biomass
yield, high growth rate, and low maintenance demand fulﬁll
the rigorous demands of industrial biotechnology (Poblete-
Castro et al., 2012). A broad portfolio of P. putida biocatalysts
for bulk chemicals such as phenol (Wierckx et al., 2005),
p-hydroxystyrene (Verhoef et al., 2009), p-hydroxybenzoate
(Verhoef et al., 2007), rhamnolipids (Wittgens et al., 2011),
polyhydroxyalkanoates (PHA; Wang et al., 2011), and (S)-
styrene oxide (Blank et al., 2008) demonstrate the great
potential of this species as a ﬂexible cell factory for the
production of chemicals in industrial biotechnology. In addition,
P. putida strains have the capability to withstand various
chemical stresses such as a second phase of toluene, octanol,
or styrene (Heipieper and de Bont, 1994; Dominguez-Cuevas
et al., 2006; Blank et al., 2008), as well as oxidative stress
(Chavarria et al., 2013) and reduced water activity (Hallsworth
et al., 2003), and thus providing a promising and versatile
chassis for the production of toxic compounds such as
oAB.
To ensure industrially relevant oAB production conditions a
full, markerless deletion of trpDC was performed in P. putida,
facilitated by the fact that in contrast to E. coli the trpEG
and trpDC genes are encoded by separate open reading
frames. Additionally the production of oAB was realized on
glucose as sole carbon source, avoiding the addition of high
amounts of complex media components such as yeast extract.
A maximum titer of 1.54 ± 0.3 g L−1 (11.23 mM) oAB was
obtained with the best performing engineered P. putida KT2440
strain (P. putida trpDC pSEVA234_aroGD146N_trpES40FG) in
tryptophan-limited fed-batch fermentations with glucose as sole
carbon source.
MATERIALS AND METHODS
Strains and Plasmids
The deletion of trpDC and pheA were performed by a clean
and markerless deletion method described by Martinez-Garcia
and de Lorenzo (2011) resulting in two knock out strains
P. putida KT2440 trpDC and P. putida KT2440 trpDC pheA. To
obtain the knockout vectors pEMG_trpDC and pEMG_pheA
were obtained via a standard restriction and ligation approach
and were transformed into chemical competent E. coli DH5α
(according to Choi et al., 2006) via electroporation. The 800-
bp ﬂanks upstream (TS1) and downstream (TS2) of the gene of
interest (trpDC and pheA) were ampliﬁed by PCR using a Pfu
polymerase (New England Biolabs) with the primers listed in
Table 1.
TS1 and TS2 were fused in a SOEing-PCR using Pfu
polymerase according to Horton (1995). The backbone (pEMG)
and the fused SOEing-PCR fragment were digested with BamHI
and EcoRI for the deletion of trpDC and with BamHI and SbfI
for the deletion of pheA. The digested backbones, TS1, and TS2
were puriﬁed (High Pure PCR Product Puriﬁcation Kit, Roche),
ligated with a T4 DNA ligase (Thermo Fisher Scientiﬁc) and
transformed into chemical competent E. coli DH5α (according
to Choi et al., 2006) via electroporation. Constructs were
veriﬁed by restriction analysis and sequencing, resulting in
pEMG_trpDC and pEMG_pheA. Genome integration of the
knockout constructs into the P. putida strains was performed
via tri-parental mating according to Ditta et al. (1980) using
E. coli HB101 pRK2013 as the helper strain and facilitated as
TABLE 1 | Primer sequences.
Name DNA sequence Tm (◦C)
TS1 trpDC
JK034f agggataacagggtaatctgaatTCGTCAGCAA
ACTCTTGATG
61.6
JK035r tttgactcgagGTTCGATCCTTAACGGCG 61.6
TS2 trpDC
JK036f aggatcgaacctcgagTCAAATGAAGCCGG
CGTT
66.1
JK037r cctgcaggtcgactctagaggatccTCGAACCAA
GGTGCTACCG
66.1
TS1 pheA
JK038f attcgagctcggtacccggggatccACTACATCG
AAACCGGCATC
61.8
JK039r ctgaactcgagTCAGCCATGCTCC
TTCTC
61.8
TS2 pheA
JK040f gcatggctgactcgagTTCAGGGGCCTTGG
GGCT
70.2
JK041r tagaagcttgcatgcctgcaggCAGTGAGTCGA
CCAGGCCAAAG
70.2
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TABLE 2 | Summary of plasmids and strains used in this study.
Description Reference
Plasmids
pEMG KmR, oriR6K, lacZa with two flanking I-SceI sites Martinez-Garcia and de Lorenzo, 2011
pSEVA234 KmR, oriBBR1, lacIq-Ptrc Silva-Rocha et al., 2013
pSW-I ApR, oriRK2, xylS, Pm→I-SceI Martinez-Garcia and de Lorenzo, 2011
pRK2013 KmR, oriRK2, oriColE1 Figurski et al., 1979
pEMG_trpDC trpDC deletion plasmid This work
pEMG_pheA pheA deletion plasmid This work
pSEVA234_trpES40FG trpES40FG expression plasmid This work
pSEVA234_aroGD146N aroGD146N expression plasmid This work
pSEVA234_aroGD146N_trpES40FG aroGD146N-trpES40FG expression plasmid This work
Strain
Psuedomonas putida KT2440 Wild-type strain derived of P. putida mt-2 cured of the
pWW0 plasmid
Bagdasarian et al., 1981
Escherichia coli DH5α supE44, DlacU169 ( f80 lacZDM15), hsdR17 (rk-mk+),
recA1, endA1, thi1, gyrA, relA
Hanahan, 1985
E. coli DH5α λpir λpir phage lysogen of DH5α De Lorenzo Lab collection
E. coli HB101 pRK2013 SmR, hsdR-M+, pro, leu, thi, recA, KmR, oriRK2,
oriColE1
Figurski et al., 1979
E. coli DH5α λpir pEMG Plasmid carrier strain Martinez-Garcia and de Lorenzo, 2011
E. coli DH5α λpir pSW-I Plasmid carrier strain Martinez-Garcia and de Lorenzo, 2011
E. coli DH5α λpir pEMG_trpDC Plasmid carrier strain This work
E. coli DH5α λpir pEMG_pheA Plasmid carrier strain This work
E. coli DH5α pSEVA234_trpES40FG Plasmid carrier strain This work
E. coli DH5α pSEVA234_aroGD146N Plasmid carrier strain This work
E. coli DH5α pSEVA234_aroGD146N_trpES40FG Plasmid carrier strain This work
P. putida KT2440 pSEVA234_trpES40FG oAB production strain This work
P. putida KT2440 pSEVA234_aroGD146N oAB production strain This work
P. putida KT2440 pSEVA234_aroGD146N_trpES40FG oAB production strain This work
P. putida KT2440 trpDC oAB production strain This work
P. putida KT2440 trpDC pSEVA234_trpES40FG oAB production strain This work
P. putida KT2440 trpDC pSEVA234_aroGD146N oAB production strain This work
P. putida KT2440 trpDC pSEVA234_aroGD146N_trpES40FG oAB production strain This work
P. putida KT2440 trpDC pheA oAB production strain This work
P. putida KT2440 trpDC pheA pSEVA234_trpES40FG oAB production strain This work
P. putida KT2440 trpDC pheA pSEVA234_aroGD146N oAB production strain This work
P. putida KT2440 trpDC pheA
pSEVA234_aroGD146N_trpES40FG
oAB production strain This work
described in Zobel et al. (2015) where the three mating strains
were streaked one above the other on a LB plate. The resulting
strains were transformed with the plasmid expressing the ISce-I
endonuclease (pSW-I; according to Choi et al., 2006). Induction
with 3-methylbenzoate was omitted due to the leaky expression
of the ISce-I nuclease. Successful construction of the knockout
strains was veriﬁed via restriction, PCR and Sanger sequencing.
The feedback insensitive overexpression constructs were
obtained via a standard restriction and ligation approach as
described above using BamHI and EcoRI for aroGD146N and
BamHI for trpES40FG. pSEVA234 (Silva-Rocha et al., 2013),
which contains an IPTG inducible lacIQ-Ptrc expression system,
was used as backbone. The genes aroGD146N (Kikuchi et al.,
1997; Albermann et al., 2014) and trpES40FG (Kwak et al.,
1999) were synthesized at Euroﬁns Genomics. A summary
of the used and constructed plasmids and of the engineered
strains is shown in Table 2. All primers were purchased at
Euroﬁns Genomics and all restriction enzymes at Thermo Fisher
Scientiﬁc.
Cultivation Conditions
For cloning and maintenance processes, E. coli strains and
P. putida strains were cultivated at 37 and 30◦C, respectively,
in LB medium supplemented with or without kanamycin
(50mg L−1) or ampicillin (100mg L−1 for E. coli and 500mg L−1
for P. putida), and/or with 1.5% (w/v) agar as needed.
Auxotrophies (tryptophan and phenylalanine) of the gene
deletion mutants were veriﬁed on solid mineral medium plates
(Wierckx et al., 2005) with 1.5% (w/v) agar, 20 mM glucose
with and without 1 mM tryptophan, and/or 1 mM phenylalanine
supplementation. Alternatively 1 mM phenylpyruvate was used
instead of phenylalanine.
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Batch-wise oAB production was performed in 500 mL shake
ﬂasks at 30◦C and 200 rpm in 50 mL mineral medium as
described in Wierckx et al. (2005) with 20 mM glucose (unless
stated diﬀerently), 50 mg L−1 kanamycin, and 1 mM IPTG,
supplemented with either 0.1 or 0.05 mM tryptophan and 1 mM
phenlypyruvate for the pheA strains. Two additional 20 mM
glucose pulses were added after 10 and 24 h unless stated
diﬀerently.
Tryptophan-limited fed-batch conditions were realized in
controlled bioreactors (BioFlo 110 or BioFlo 115, Eppendorf /
New Brunswick Scientiﬁc) with a starting volume of 400 mL.
The initial fermentation medium consisted of mineral medium
with 50 mM glucose, a twofold phosphate buﬀer concentration,
a threefold (NH4)2SO4 concentration, a onefold trace element
solution, 1 mM IPTG, 50 mM kanamycin, and 0.1 mM
tryptophan. After the initial batch phase, the feed was switched
on at a rate of 2 mL h−1 consisting of a mixed solution of
1 M glucose and 0.5 mM (glucose to tryptophan molar ratio
of 2,000:1) or 1 mM (glucose to tryptophan molar ratio of
1,000:1) tryptophan. To compensate for the increasing biomass
concentrations the 1 mM tryptophan feed was increased to
6 mL h−1. The fermentations were performed at 30◦C, with 500–
1,200 rpm agitation (dO2 regulated agitation cascade with a lower
limit of 35%), with 1 vvm headspace aeration of compressed air.
The pH was regulated to pH = 7 with 2 M KOH and 4 M H2SO4.
Analytics
The biomass concentration was measured with a
spectrophotometer (Ultrospec 10, GE Healthcare Life Sciences).
In this device the OD600 correlates to cell dry weight (CDW): 1
OD600 = 0.505 gCDW L−1. The samples taken during cultivation
were centrifuged at 13,300 rpm for 3 min and stored at −20◦C
for further analysis. To follow the consumption of the glucose
and derivatives (gluconate and 2-ketogluconate) by the P. putida
KT2440 strains, a Beckman HPLC equipped with an organic acid
resin column (polystyrol-divinylbenzol copolymer, PS-DVB:
300 × 8.0 mm, CS-Chromatographie) was used with 5 mM
H2SO4 as eluent at a ﬂow of 0.8 mL h−1 for 11 min at 75◦C.
Detection was realized with an UV detector at a wavelength of
210 nm and a RI detector. The oAB production was analyzed with
a reverse phase column (LiChrosorb 100 RP-18, 250 × 4 mm,
Merck), at a ﬂow of 1.2 mL h−1 [pump gradient of H2O + 0.1%
TFA (pump A) and of MeOH (pump B): 0–2 min 90% A, 2–
12 min gradient 0–90% A, 12–14 min 0% A, 14–15 min gradient
0–90% A, and 15–16 min 90% A] at 30◦C. Detection was realized
with an UV detector at a wavelength of 257 nm and a RI detector.
RESULTS AND DISCUSSION
Metabolic Engineering of oAB
Production Strains
In order to establish oAB production in P. putida, the
trpDC and pheA genes were knocked out using the I-SceI-
based pEMG system (Martinez-Garcia and de Lorenzo, 2011).
Disruption of the trpDC genes, which encode an anthranilate
phosphoribosyltransferase (TrpD) and an indole-3-glycerol
FIGURE 1 | Schematic oAB production pathway including the
metabolic engineering targets investigated in this study
(overexpression of aroGD146N trpES40FG and deletion of trpDC and
pheA). PEP, phosphoenolpyruvate; E4P, erythrose-4-phosphate; DAHP,
3-Deoxy-D-arabinoheptulosonate-7-phosphate.
phosphate synthase (TrpC), leads to a tryptophan auxotrophy
and enables the accumulation of oAB (Figure 1). Disruption
of the pheA gene, which encodes a bifunctional chorismate
mutase/prephenate dehydratase enzyme responsible for the ﬁrst
two steps of the synthesis of phenylalanine and tyrosine, possibly
increases the metabolic ﬂux toward oAB by reducing the drain
on its primary precursor chorismate (Zhao et al., 2011). Contrary
to other established production hosts, the pheA deletion only
requires phenylalanine to complement growth since P. putida
can convert phenylalanine to tyrosine (Molina-Henares et al.,
2009). The corresponding auxotrophies were veriﬁed on mineral
medium plates (Table 3).
TABLE 3 | Auxotrophy supplementation of P. putida KT2440 trpDC and
pheA knockouts.
Name Supplementationa Growth
P. putida KT2440 None +
trp +
phe +
trp + phe +
P. putida KT2440 trpDC None −
Trp +
P. putida KT2440 trpDC pheA None −
Trp −
trp + phe +
trp + pp +
aMineral medium plates with 20 mM glucose supplemented with 1 mM tryptophan
(trp), phenylalanine (phe), or phenylpyruvate (pp).
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FIGURE 2 | oAB production profiles of various P. putida KT2440 strains
in shake flasks. Biomass growth (A) and oAB production (B) of the following
Pseudomonas putida KT2440 strains in an initial screening experiment:
, trpDC pSEVA234_trpES40FG; •, trpDC pSEVA234_aroGD146N;
, trpDC pSEVA234_aroGD146N_trpES40FG; , trpDC pheA
pSEVA234_trpES40FG; •, trpDC pheA pSEVA234_aroGD146N;
, trpDC pheA pSEVA234_aroGD146N_trpES40FG; ,
pSEVA234_aroGD146N_trpES40FG. All cultures were performed in mineral
medium with 20 mM initial glucose concentration and addition of tryptophan
and/or phenylpyruvate as described above. The arrows indicate the addition
of glucose to a concentration of 20 mM.
In the knockout process, the deletion of pheA could only
be obtained by supplementation with phenylpyruvate. The ﬁnal
step of the knockout procedure (induction of the double strand
break) should theoretically yield a one-to-one ratio of wildtype
to knockout allele. However, selection on LB- or LB medium
with phenylalanine resulted in the wildtype allele only, even
after testing >1,000 colonies either by PCR or by screening for
phenylalanine auxotrophy. This may be attributed to the ability
of P. putida to degrade phenylalanine and tyrosine. Possibly,
supplementation with phenylpyruvate instead of phenylalanine
reduced the induction of genes encoding the phenylalanine and
tyrosine catabolic pathway (Arias-Barrau et al., 2004), facilitating
the successful isolation of the knockout strain. The ﬁnal pheA
knockout auxotroph could be complemented with phenylalanine
in mineral medium. However, in this case a severe negative eﬀect
on the ﬁtness of the mutant caused by the deletion of pheA was
observed. Therefore, all subsequent pheA complementation
were done with phenylpyruvate.
To further optimize the production of oAB in P. putida,
feedback insensitive pSEVA234-based (Silva-Rocha et al., 2013)
FIGURE 3 | Detailed profiles of •, cell dry weight; , oAB; ♦,
tryptophan (trp); , dehydroshikimate (DHS) concentrations of the
best selected strain P. putida KT2440 trpDC pSEVA234_trpES40FG
generated under slightly optimized production conditions. All cultures
were performed in mineral medium with 20 mM initial glucose concentration
and addition of tryptophan and/or phenylpyruvate as described above. The
arrows indicate the addition of glucose to a concentration of 20 mM.
overexpression constructs for trpES40FG and aroGD146N, or
both genes in one operon structure, were transformed to
the respective mutants under the IPTG-inducible LacIQ-Ptrc
system. These genes encode feedback insensitive variants of
anthranilate synthase and 3-deoxy-D-arabino-heptulosonate-7-
phosphate (DHAP) synthase, respectively, and are known to
enhance oAB production in E. coli (Balderas-Hernandez et al.,
2009, 2014; Sun et al., 2013). Figure 1 shows the exemplarily oAB
production pathway and gives on overview over the metabolic
engineering targets investigated in this study.
Evaluation of oAB Production Strains in
Shake Flasks
The P. putida strains engineered for the production of oAB
(listed in Table 2) were initially assessed in shake ﬂasks
(Figures 2A,B) and under slightly optimized production
conditions a maximum titer of 0.25 ± 0.004 g L−1 (1.83 mM)
oAB with glucose as sole carbon source was achieved (Figure 3).
The three trpDC strains bearing either trpES40FG, aroGD146N
or both, have shown no signiﬁcant diﬀerences in maximal
oAB titers, although the onset of production was earlier in the
P. putida KT2440 trpDC pSEVA234_aroGD146N_trpES40FG.
Interestingly, oAB production was also observed with P. putida
KT2440 pSEVA234_aroGD146N_trpES40FG (without trpDC
deletion) while no tryptophan was secreted, although the
maximal titer was lower than that of the trpDC strains. This
can be explained by the transcriptional repression of trp genes by
tryptophan through the TrpR repressor (Maurer and Crawford,
1971; Wierckx et al., 2008). Likely, an increase of intracellular
tryptophan caused repression of the native trp genes, leading to
anthranilate accumulation due to the heterologous expression of
trpES40FG.
A strong connection was observed between tryptophan
limitation and oAB production. When supplementing the
auxotrophic strains with tryptophan the oAB production was
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FIGURE 4 | Tryptophan-limited fed-batch cultures of P. putida KT2440 trpDC pSEVA234_aroGD146N_trpES40FG in controlled bioreactors with
different feeding approaches. (A) Feed molar ratio of glucose to tryptophan 1,000:1. (B) Feed molar ratio of glucose-to-tryptophan 2,000:1. •, cell dry weight;
, oAB concentration. The arrows indicate the start of the feed after the initial batch phase.
induced only upon depletion of the added tryptophan. Strains
expressing both aroGD146N and trpES40FG produced oAB at
earlier time points compared to strains with only one of
the feedback insensitive genes, indicating somewhat alleviated
feedback insensitivity to tryptophan (Figure 2). With the non-
auxotrophic P. putida pSEVA234_aroGD146N_trpES40FG, where a
supplementation with tryptophan was not required, oAB titers
were signiﬁcantly higher at earlier time points, indicating no
inhibition by tryptophan. However, the ﬁnal oAB titers were 34%
lower compared to the P. putida trpDC strains, indicating a
positive eﬀect of the deletion of trpDC.
As indicated above, a clear negative eﬀect of the deletion of
pheA on the growth behavior was observed. Whereas P. putida
KT2440 pSEVA234_trpES40FG and P. putida KT2440 trpDC
pSEVA234_trpES40FG were able to grow up to 3.6 g L−1
CDW and 2.4 g L−1 CDW, respectively; P.putida KT2440
trpDC pheA pSEVA234_trpES40FG only reached a maximal
CDW concentration of 1.4 g L−1 after 10 hours when
supplemented with 1 mM phenylpyruvate. Further addition
of glucose and/or tryptophan could neither initiate growth
to higher CDW concentrations, nor did it improve oAB
production. Normal growth was only fully rescued when
supplementing high amounts of phenylpyruvate (≥5 mM)
which would make the overall process highly uneconomical.
Additionally, ﬁnal oAB titers were still 49% lower than with
the trpDC strains, indicating a negative eﬀect of the pheA
deletion for the production of oAB in this organism. Thus,
the most promising strain engineered for the production of
oAB is P. putida trpDC pSEVA234_aroGD146N_trpES40FG as it
reached high titers of oAB and showed reduced sensitivity to
tryptophan.
Dehydroshikimate, a metabolic intermediate of the shikimate
pathway and thus a precursor of oAB, accumulated as a
by-product in all strains engineered for oAB production in
shake ﬂasks, indicating shikimate dehydrogenase as a likely
bottleneck (Figure 3). This hypothesis is also supported by
the transcriptome data sets of Wierckx et al. (2009) and
Verhoef et al. (2010) showing upregulated 3-dehydroquinate
and dehydroshikimate genes in the analyzed phenol and
p-hydroxybenzoate production strains obtained by a ﬂuoro-
analog mutant screening.
Production of oAB in Controlled
Bioreactors
The potential of P. putida trpDC pSEVA234_aroGD146N_
trpES40FG to produce oAB was further assessed in tryptophan-
limited fed batch cultures to circumvent the observed inhibition
by tryptophan and maximize ﬁnal oAB titers. A glucose-to-
tryptophan molar ratio of 400:1 was estimated for biomass
growth alone based on the initial shake ﬂask experiments.
Therefore, two diﬀerent feeding approaches with a molar ratio
of glucose to tryptophan of 1,000:1 and 2,000:1 were used to
ensure a tryptophan limitation without excessive accumulation
of glucose or its derivatives. Under these conditions a maximal
titer of 1.54 ± 0.3 g L−1 oAB was reached from glucose as sole
carbon source using the 2,000:1 feed (Figure 4). The higher ratio
of glucose to tryptophan led to a more severe growth limitation,
with CDW increasing only marginally during the production of
oAB. In contrast, the 1,000:1 feed enabled more biomass growth
at the cost of oAB production, leading to a ﬁnal product titer
of 1.0 ± 0.07 g L−1. The product per substrate yield (based on
consumed carbon source) for both conditions is relatively similar
at 3.6 ± 0.5% (g/g) for the 1,000:1 feed and 3.5 ± 0.5% (g/g)
for the 2,000:1 feed. oAB levels increased fairly linearly until the
production stopped abruptly. Since the level of oAB produced
is well below growth-inhibiting concentrations for P. putida
(data not shown), oAB production is most likely stopped due
to product inhibition, a known phenomenon for the production
of aromatics (Gibson and Pittard, 1968; Wierckx et al., 2008;
Rodriguez et al., 2014). This product inhibition likely takes place
at the level of the anthranilate synthase. Indeed, the anthranilate
synthase complex of other organisms is already inhibited by
oAB concentrations in the micromolar range (Cordaro et al.,
1968; Henderson et al., 1970; Francis et al., 1978). The oAB
titers obtained with P. putida KT2440 in this study are about
10-fold lower than those achieved by Balderas-Hernandez et al.
(2009). The diﬀerence can most likely be attributed to the
supplementation of 30 g/L yeast extract by these researchers,
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which can provide oAB precursors and increases the general
stress tolerance of microorganisms. This apparent positive eﬀect
of yeast extract on oAB production should be further investigated
in order to elucidate the responsible components.
In the initial batch phase, the 50 mM glucose were entirely
consumed for the production of biomass. Tryptophan limiting
conditions were conﬁrmed by HPLC analysis throughout the
fermentation (<0.1 mM). Carbon source, either as glucose or as
gluconate and 2-ketogluconate, were constantly present during
the feed phase at total concentrations between 0.4 and 8.6 g L−1.
In some fermenters, a prolonged incubation led to a decrease of
oAB concentrations over time. Possibly, polymerization of oAB
and/or its conversion products occurred.
CONCLUSION
Microbial production of oAB under industrial relevant
conditions from glucose as sole carbon source was achieved in
P. putidaKT2440 via the biosynthesis pathway of aromatic amino
acids. A strong connection between a tryptophan limitation
and oAB production was observed even with strains bearing
feedback insensitive overexpression constructs of aroGD146N and
trpES40FG. Under tryptophan limiting fed-batch conditions, a
maximum titer of 1.54 ± 0.3 g L−1 oAB was achieved with
P. putida KT2440 trpDC pSEVA234_aroGD146N_trpES40FG.
This ﬁnal achieved concentration is in the same range as other
aromatics produced by P. putida strains (Nijkamp et al., 2005,
2007; Verhoef et al., 2007); although the titer is lower than that
of previously published works with E. coli (Balderas-Hernandez
et al., 2009). However, the supplementation with yeast extract was
avoided and oAB was only produced from glucose. In addition, to
ensure long term strain stability, one of the main requirements in
industrial biotechnology, a stable and markerless deletion of the
genes responsible for the conversion of oAB towards tryptophan
(trpDC) was used. Nevertheless, the oAB titer and yield reached
with P. putida KT2440 are below those which are required to
realize an industrial feasible process. Further improvement is
required, e.g., by more in-depth metabolic engineering (e.g.,
overexpression of tkt: Balderas-Hernandez et al., 2009) as well
as by in situ product removal to alleviate product inhibition.
Further research on the mechanism of product inhibition of oAB
production could also lead to additional metabolic engineering
targets to improve microbial oAB production.
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